BHST
BioHarvest Sciences Inc.
BHST lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
BHST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
BHST's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BHST PE Valuation
BHST has no meaningful PE right now: it lost money over the past year.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
BHST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect BHST's losses to shrink, with revenue growing.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BHST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.54 | +$0.16 |
| Q1 2026 | -$0.62 | -$0.12 |
| Q4 2025 | -$0.63 | +$0.22 |
| Q3 2025 | -$0.68 | +$0.54 |
| Q2 2025 | -$0.70 | +$0.49 |
| Q1 2025 | -$0.50 | +$0.86 |
| Q4 2024 | -$0.85 | +$0.09 |
| Q3 2024 | -$1.22 | -$0.61 |
BHST has the stronger earnings trend. Trailing diluted EPS is down 177% for BHST versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
BHST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +3.8% |
| Q1 2026 | $8.5M | +8.2% |
| Q4 2025 | $9.1M | +25% |
| Q3 2025 | $9.1M | +39% |
| Q2 2025 | $8.5M | +41% |
| Q1 2025 | $7.9M | +47% |
| Q4 2024 | $7.3M | +61% |
| Q3 2024 | $6.5M | +102% |
BHST's revenue has grown year over year every quarter since late 2020: $9M last quarter, up 3.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -7.1 points |
| Q1 2026 | -22% | +0.3 points |
| Q4 2025 | -12% | +11 points |
| Q3 2025 | -10% | +22 points |
| Q2 2025 | -21% | +8.1 points |
| Q1 2025 | -22% | +4.8 points |
| Q4 2024 | -23% | +33 points |
| Q3 2024 | -32% | +30 points |
BHST has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over BHST on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
BHST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.3M | -$1.2M |
| Q1 2026 | -$2.2M | -$59K |
| Q4 2025 | -$2.9M | +$387.3K |
| Q3 2025 | -$2.5M | -$270.7K |
| Q2 2025 | -$2.1M | +$542.1K |
| Q1 2025 | -$2.1M | -$311K |
| Q4 2024 | -$3.3M | -$126.9K |
| Q3 2024 | -$2.3M | -$836K |
BHST has the edge over EOSE on cash flow, with more consistent year-over-year improvement.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
BHST Net Leverage
BHST's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BHST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 17.3 | Oversold |
BHST's weekly RSI is 33 (neutral) and its Stochastic is 17 (oversold).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BHST PE vs Industrials Sector
BHST has no meaningful PE right now: it lost money over the past year.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
BHST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0% above |
| 20 week MA | $1.97 | 17% below |
| 50 week MA | $3.45 | 53% below |
| 100 week MA | $5.30 | 69% below |
BHST has stronger trend alignment. BHST is above 1 of 4 weekly averages versus EOSE above 0 of 5.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
BHST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.80 | $6.15 | +28% |
| 2025 | $6.15 | $5.33 | -13% |
| 2026 YTD | $5.33 | $1.63 | -69% |
BHST has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.